236 related articles for article (PubMed ID: 9257815)
21. Immune responses in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice.
Michaelides MC; Simms ES
Immunology; 1977 Jun; 32(6):981-8. PubMed ID: 885591
[TBL] [Abstract][Full Text] [Related]
22. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes.
Isakov N; Segal S
Immunobiology; 1983 May; 164(5):402-16. PubMed ID: 6873999
[TBL] [Abstract][Full Text] [Related]
23. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
Morimoto M; Ohji T; Iwata H; Hayashi T
Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
[TBL] [Abstract][Full Text] [Related]
24. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
[TBL] [Abstract][Full Text] [Related]
25. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.
Chen Z; Rowland RR; Anderson GW; Palmer GA; Plagemann PG
J Virol; 1997 Apr; 71(4):2913-20. PubMed ID: 9060649
[TBL] [Abstract][Full Text] [Related]
26. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice.
Cafruny WA; Plagemann PG
Infect Immun; 1982 Sep; 37(3):1001-6. PubMed ID: 7129626
[TBL] [Abstract][Full Text] [Related]
27. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
Monteyne P; Coutelier JP
J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
[TBL] [Abstract][Full Text] [Related]
28. Lactate dehydrogenase-elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants.
Weiland E; Grossmann A; Thiel HJ; Weiland F
J Gen Virol; 1990 May; 71 ( Pt 5)():1233-6. PubMed ID: 2345370
[TBL] [Abstract][Full Text] [Related]
29. Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.
Robertson SJ; Ammann CG; Messer RJ; Carmody AB; Myers L; Dittmer U; Nair S; Gerlach N; Evans LH; Cafruny WA; Hasenkrug KJ
J Virol; 2008 Jan; 82(1):408-18. PubMed ID: 17959678
[TBL] [Abstract][Full Text] [Related]
30. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.
Cafruny WA; Chan SP; Harty JT; Yousefi S; Kowalchyk K; McDonald D; Foreman B; Budweg G; Plagemann PG
Virus Res; 1986 Sep; 5(4):357-75. PubMed ID: 3022497
[TBL] [Abstract][Full Text] [Related]
31. The mechanism of modulation of humoral immune responses after infection of mice with lactic dehydrogenase virus.
Isakov N; Feldman M; Segal S
J Immunol; 1982 Feb; 128(2):969-75. PubMed ID: 7198665
[No Abstract] [Full Text] [Related]
32. Divergent roles of IFNs in the sensitization to endotoxin shock by lactate dehydrogenase-elevating virus.
Le-Thi-Phuong T; Dumoutier L; Renauld JC; Van Snick J; Coutelier JP
Int Immunol; 2007 Nov; 19(11):1303-11. PubMed ID: 17914119
[TBL] [Abstract][Full Text] [Related]
33. Replication of lactate dehydrogenase-elevating virus in cells infected with murine leukaemia viruses in vitro.
Inada T; Yamazaki S
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2437-44. PubMed ID: 1655956
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.
Cafruny WA; Jones QA; Haven TR; Zitterkopf NL; Plagemann PG; Rowland RR
Virus Res; 2003 Mar; 92(1):83-7. PubMed ID: 12606079
[TBL] [Abstract][Full Text] [Related]
35. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
Cafruny WA; Bradley SE
J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
[TBL] [Abstract][Full Text] [Related]
36. Live lactate dehydrogenase-elevating virus (LDV) induces suppressor T cells that inhibit the development of delayed hypersensitivity to LDV.
Inada T; Mims CA
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2103-12. PubMed ID: 2944991
[TBL] [Abstract][Full Text] [Related]
37. Characterization of lactate dehydrogenase-elevating virus ORF6 protein expressed by recombinant baculoviruses.
Takahashi-Omoe H; Omoe K; Matsushita S; Inada T
Comp Immunol Microbiol Infect Dis; 2004 Nov; 27(6):423-31. PubMed ID: 15325515
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of C-type viral leukemogenesis. I. Correlation of in vitro lymphocyte blastogenesis to viremia and leukemia.
Lee JC; Ihle JN
J Immunol; 1979 Nov; 123(5):2351-8. PubMed ID: 90708
[TBL] [Abstract][Full Text] [Related]
39. Exacerbation of murine malaria by concurrent infection with lactic dehydrogenase-elevating virus.
Henderson DC; Tosta CE; Wedderburn N
Clin Exp Immunol; 1978 Aug; 33(2):357-9. PubMed ID: 719954
[TBL] [Abstract][Full Text] [Related]
40. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
